The reported statements, read against the company's own industry.
Financials view
Market Capitalization
4.89BCNY
733.64M · vs all stocks (USD)
Updated Oct 21, 2026
Trailing P/E
220.60x
Updated Oct 21, 2026
Revenue (TTM)
980.63MCNY
146.99M · vs all stocks (USD)
Updated Oct 21, 2026
Profit Margin
2.45%
Updated Oct 21, 2026
Beta
0.3350x
vs all stocks
Updated Oct 21, 2026
52-Week Change
-48.91%
vs all stocks
Updated Oct 21, 2026
Market Capitalization
4.89BCNY
733.64M · vs all stocks (USD)
Updated Oct 21, 2026
Enterprise Value
4.77BCNY
714.54M · vs all stocks (USD)
Updated Oct 21, 2026
Trailing P/E
220.60x
Updated Oct 21, 2026
Forward P/E
18.38x
Updated Oct 21, 2026
Price to Sales (TTM)
4.99x
Updated Oct 21, 2026
Price to Book (MRQ)
7.07x
Updated Oct 21, 2026
Enterprise to Revenue
4.86x
Updated Oct 21, 2026
Enterprise to EBITDA
135.68x
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 81.79×.Updated Oct 21, 2026
Gross Margin
21.04%
Updated Oct 21, 2026
Profit Margin
2.45%
Updated Oct 21, 2026
Operating Margin
6.72%
Updated Oct 21, 2026
Return on Assets (TTM)
1.63%
Updated Oct 21, 2026
Return on Equity (TTM)
3.55%
Updated Oct 21, 2026
Revenue (TTM)
980.63MCNY
146.99M · vs all stocks (USD)
Updated Oct 21, 2026
Revenue per Share (TTM)
2.21CNYUpdated Oct 21, 2026
Quarterly Revenue Growth
-4.50%
Updated Oct 21, 2026
Gross Profit (TTM)
199.97MCNY
29.97M · vs all stocks (USD)
Updated Oct 21, 2026
EBITDA (TTM)
58.28MCNY
8.74M · vs all stocks (USD)
Updated Oct 21, 2026
Net Income (TTM)
24.06MCNY
3.61M · vs all stocks (USD)
Updated Oct 21, 2026
Quarterly Earnings Growth (YoY)
-4.00%
Updated Oct 21, 2026
Operating Cash Flow (TTM)
172.25MCNY
25.82M · vs all stocks (USD)
Updated Oct 21, 2026
Levered Free Cash Flow (TTM)
171.44MCNY
25.70M · vs all stocks (USD)
Updated Oct 21, 2026
5-Year Average Dividend Yield
0.14%
vs all stocks
Updated Oct 21, 2026
Payout Ratio
0.00%
Updated Oct 21, 2026
Revenue
1.03BCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
820.01MCNYFY2025 · Dec 31, 2025
Gross Profit
210.39MCNYFY2025 · Dec 31, 2025
Operating Income
48.48MCNY
7.27M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
28.59MCNYFY2025 · Dec 31, 2025
Income Tax Expense
-103.02KCNYFY2025 · Dec 31, 2025
Net Income
28.70MCNYFY2025 · Dec 31, 2025
EBIT
39.33MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
58.28MCNYFY2025 · Dec 31, 2025
Research & Development
30.65MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
29.15MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
6.49MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
1.21MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
10.74MCNYFY2025 · Dec 31, 2025
EPS (Basic)
0.0647CNYFY2025 · Dec 31, 2025
EPS (Diluted)
0.0647CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
443.52MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
443.52MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
28.70MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
108.25MCNYFY2025 · Dec 31, 2025
Free Cash Flow
106.13MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
403.65MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
28.70MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
12.05MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
12.92MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
54.58MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-2.13MCNYFY2025 · Dec 31, 2025
Net Acquisitions
92.61KCNYFY2025 · Dec 31, 2025
Purchase of Investments
-410.97MCNYFY2025 · Dec 31, 2025
Sale of Investments
390.97MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-22.04MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
292.00MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-320.09MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-10.34MCNYFY2025 · Dec 31, 2025
Other Financing Charges
-6.71MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-45.14MCNYFY2025 · Dec 31, 2025
Shares Outstanding
443.75MSharesUpdated Oct 21, 2026
Float Shares
347.30MSharesUpdated Oct 21, 2026
% Held by Insiders
28.23%
vs all stocks
Updated Oct 21, 2026
% Held by Institutions
1.85%
vs all stocks
Updated Oct 21, 2026
Total Cash (MRQ)
299.38MCNY
44.87M · vs all stocks (USD)
Updated Oct 21, 2026
Total Cash per Share (MRQ)
0.6750CNYUpdated Oct 21, 2026
Total Debt (MRQ)
242.94MCNY
36.41M · vs all stocks (USD)
Updated Oct 21, 2026
Total Debt to Equity (MRQ)
0.3507x
Updated Oct 21, 2026
Current Ratio (MRQ)
1.90x
Updated Oct 21, 2026
Book Value per Share (MRQ)
1.56CNYUpdated Oct 21, 2026
Total Assets
1.25BCNY
187.35M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
1.10BCNYFY2025 · Dec 31, 2025
Total Liabilities
568.40MCNYFY2025 · Dec 31, 2025
Total Non-current Assets
150.01MCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
10.57MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
557.83MCNYFY2025 · Dec 31, 2025
Cash
403.65MCNYFY2025 · Dec 31, 2025
Cash Equivalents
14.26MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
417.91MCNYFY2025 · Dec 31, 2025
Other Short-term Investments
7.03MCNYFY2025 · Dec 31, 2025
Accounts Receivable
242.52MCNYFY2025 · Dec 31, 2025
Inventory
403.63MCNYFY2025 · Dec 31, 2025
Accounts Payable
25.37MCNYFY2025 · Dec 31, 2025
Short-term Debt
286.44MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
20.62MCNYFY2025 · Dec 31, 2025
Long-term Debt
5.11MCNYFY2025 · Dec 31, 2025
Other Non-current Liabilities
5.40MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
443.75MCNYFY2025 · Dec 31, 2025
Retained Earnings
-111.19MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
681.54MCNY
102.16M · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
9.65CNYUpdated Oct 21, 2026
52-Week High
25.99CNYUpdated Oct 21, 2026
52-Week Change
-48.91%
vs all stocks
Updated Oct 21, 2026
Beta
0.3350x
vs all stocks
Updated Oct 21, 2026
50-Day MA
11.77CNYUpdated Oct 21, 2026
200-Day MA
14.52CNYUpdated Oct 21, 2026
Avg 10-Day Volume
7.26MSharesUpdated Oct 21, 2026
Avg 30-Day Volume
9.82MSharesUpdated Oct 21, 2026
Diluted EPS (TTM)
0.0500CNYUpdated Oct 21, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
The price sits below its 40-week average, on three profitable years and cash above profit.
Reads
Drawdown With FCF And Cash Backing
Well below its peak, with three years of positive free cash flow behind it.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 6.49: safe zoneNotable
Altman Z-Score: 6.49
High earnings qualityNotable
Earnings Quality Score: 2.21
Supply Chain
Downstream position: depends on 10 industries, supplies 5Notable
Outgoing: 5.00Incoming: 10.00
High connectivity hub: 15 industry connectionsNotable
Total Connections: 15.00
Scale
Levered free cash flow is $25.7M, above the global median of $18.58MNotable